Bruce Neal's Publications

About Bruce Neal's Publications

Executive Director, The George Institute for Global Health, Australia

  • Randomized Trials Fit for the 21st Century. A Joint Opinion from the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation

    Global Heart Date published:

  • Protocol for the Metformin Aneurysm Trial (MAT): a placebo-controlled randomised trial testing whether metformin reduces the risk of serious complications of abdominal aortic aneurysm

    Trials Date published:

  • Salt Substitute and Cardiovascular Events and Death

    New England Journal of Medicine Date published:

  • Availability, healthiness, and price of packaged and unpackaged foods in India: A cross-sectional study

    Nutrition and Health Date published:

  • Factors Associated With the Use of a Salt Substitute in Rural China

    JAMA Network Open Date published:

  • Association Between Circulating GDF-15 and Cardio-Renal Outcomes and Effect of Canagliflozin: Results From the CANVAS Trial

    Journal of the American Heart Association Date published:

  • The relative importance of primary food choice factors among different consumer groups: A latent profile analysis

    Food Quality and Preference Date published:

  • Heart Failure Therapies for the Prevention of HER2-Monoclonal Antibody-Mediated Cardiotoxicity: A Systematic Review and Meta-Analysis of Randomized Trials

    Cancers Date published:

  • Estimating the potential impact of the Australian government’s reformulation targets on household sugar purchases

    International Journal of Behavioral Nutrition and Physical Activity Date published:

  • The estimated health impact of sodium reduction through food reformulation in Australia: A modeling study

    PLOS Medicine Date published:

  • The Role of Sodium Glucose Cotransporter-2 Inhibitors in Atherosclerotic Cardiovascular Disease: A Narrative Review of Potential Mechanisms

    Cells Date published:

  • Effects of canagliflozin on hyperkalaemia and serum potassium in people with diabetes and chronic kidney disease: insights from the CREDENCE trial

    Date published:

  • KidneyIntelX as an Enrichment Tool for Clinical Trials in Early Diabetic Kidney Disease

    Journal of the American Society of Nephrology Date published:

  • Effects of canagliflozin on hyperkalaemia and serum potassium in people with diabetes and chronic kidney disease: insights from the CREDENCE trial

    European Heart Journal Date published:

  • Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial

    The Lancet Date published:

  • Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis

    The Lancet Date published: